Publication | Open Access
Ibrutinib for previously untreated and relapsed or refractory chronic lymphocytic leukaemia with TP53 aberrations: a phase 2, single-arm trial
365
Citations
22
References
2014
Year
Hematological MalignancyLymphoid NeoplasiaTp53 AberrationsSingle-arm TrialMedicineImmunologyPathologyImmune Checkpoint InhibitorPhase 2ImmunotherapyOncology
| Year | Citations | |
|---|---|---|
Page 1
Page 1